Pazopanib HCL: A Potent Treatment for Kidney Cancer
Pazopanib HCL, sold under the brand name Votrient, is a powerful medication primarily used to treat advanced renal cell carcinoma (RCC), a type of kidney cancer, and soft tissue sarcoma. Developed by GlaxoSmithKline, Pazopanib works as a tyrosine kinase inhibitor (TKI) that targets multiple proteins in cancer cells.
Visit-https://www.medicapharma.com/s....hop/active-pharmaceu
Like
Comment
Share
